top of page

Building AI - Powered Solutions for Rapid, Accurate, Cost-Effective Bacteria Analysis

The Company

Fighting deadly pathogens and anti-microbial resistant bacteria (AMR) is a major global challenge. Our MedTech startup, BioKubes™ registered in Delaware, USA, has developed an advanced rapid bacteria identification technology.

 

Lessening AMR’s impact will require incremental contributions from the global research community. Our fully automated platform combines advanced bioimaging, robotics, and machine learning classification to produce rapid cost-effective bacteria screenings.

 

The BioKubes™ user-friendly design allows microbiology and non-microbiology researchers (genomics, pharma, environment, medicine) to conduct highly accurate multi-dimensional bacteria analysis.

 

BioKubes' expansion plan will produce new hardware/software applications developed internally or in partnership with research institutions and innovative startups in an open innovation partnership.

The Company
The Solution

The Solution

Screen Shot 2021-08-14 at 11.10.13 AM.png
biokubswithline.png
with shadow.png
Higher
  • Accuracy

  • Output

  • Consistency

Lower
  • Human Error

  • Cross Contamination

  • Cost

Easier
  • Data Sharing

  • Collaboration

  • Documentation

Screen Shot 2021-08-07 at 4.34.17 PM.png
Validation Results

The Validation

validation1.png
Collaboration

Partners

linksium.png
شعار-وادي-مكة-للإستثمار.png

Collaborators

UGA.png
Logo_CHU_Grenoble_alpes.png
LIG Grenoble
Informatics Laboratory
Picture5.tif
NAWAH.png
The Team

The Team

Reem_edited.jpg
Frame 2.jpg

Ahmed Alsoffi, CTO

Dr. Reem Tambosi, CEO

Frame 1.jpg

Robin Freeman, Operations

Research Partners

Frame 4.jpg

Dr. Ahmad Lbath, President, Smart Computing, Carnot Institute

image_2021-08-14_002326.png

Dr. Max Maurin, Lab Director, CHU-UGA

Frame 5.jpg

Dr. Walid Rachidi, Vice Dean, Pharmacy UGA

Contact

Contact Us

Thanks for submitting!

bottom of page